Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis

Wiener Klinische Wochenschrift

Volumn 110, Issue 3, 1998, Pages 79-88

  Wimazal, F ^a   Walchshofer, S ^a   Baghestanian, M ^a   Chott, A ^b   Sperr, W R ^a   Kopp, C ^a   Sillaber, C ^a   Semper, H ^a   Horny, H P ^c   Trondle U ^d   Fodinger M ^d   Schwarzinger, I ^d   Lechner, K ^a   Valent, Peter ^a,d  

^a Division of Hematology

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

c kit; Mast cells; Mastocytosis; MDS; MITF; SCF

Indexed keywords

PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRYPTASE;

ARTICLE; BONE MARROW DISEASE; CELL MATURATION; CLINICAL FEATURE; EVOLUTION; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MAST CELL; MASTOCYTOSIS; MYELODYSPLASTIC SYNDROME; POINT MUTATION; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

AGED; ANEMIA, REFRACTORY; ANEMIA, SIDEROBLASTIC; BONE MARROW; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MALE; MAST CELLS; MASTOCYTOSIS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MYELODYSPLASTIC SYNDROMES; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; STEM CELL FACTOR; TRANSCRIPTION FACTORS;

EID: 6844252888     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Agis H, Beil WJ, Bankl HC, Füreder W, Sperr WR, Ghannadan M, et al. (1996) Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunopheno-typing. Leuk Lymphoma 22: 187-204
2. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA (1991) Expression of the YB5.B8 antigen (c-kit protooncogene product) in normal human bone marrow. Blood 78: 30-37
3. Baghestanian M, Bankl HC, Sillaber C, Beil WJ, Radaszkiewicz T, Füreder W, et al. (1996) A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia 10: 159-166
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189-199
5. Castells MC, Irani AM, Schwartz LB (1987) Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 138: 2184-2189
6. Cattoretti G, Pileri S, Parravicini C, Becker MH, Poggi S, Bifulco C, et al. (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171: 83-98
7. Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE (1993) Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82: 1151-1158
8. Dalton R, Chan L, Batten E, Eridani S (1986) Mast cell leukemia: evidence for bone marrow origin of the pathologic clone. Br J Haematol 64: 397-406
9. Ebi Y, Kanakura Y, Jippo-Kanemoto T, Tusjimura T, Furitsu T, Ikeda H, et al. (1992) Low c-kit expression of cultured mast cells mi/mi genotype may be involved in their defective responses to fibroblasts that express the ligand for c-kit. Blood 80: 1454-1462
10. Födinger M, Fritsch G, Winkler K, Emmmger W, Mitterbauer G, Gadner H, et al. (1994) Origin of human mast cells: Development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84: 2954-2959
11. Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M, et al. (1995) Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia. J Pathol 177: 139-146
12. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, et al. (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of the c-kit product. J Clin Invest 92: 1736-17440
13. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088
14. Horan RF, Austen KF (1991) Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 96: 5S-13S
15. Horny H-P, Parwaresch MR, Lennert K (1985) Bone marrow findings in systemic mastocytosis. Hum Pathol 16: 808-814
16. Horny H-P, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, et al.: Clinical significance and diagnostic utility of immunostaining for tryptase in patients with mastocytosis (manuscript submitted)
17. Horny H-P, Ruck M, Wehrmann M, Kaiserling E (1990) Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol 76: 186-193
18. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
19. rc type. Clin Exp Allergy 20: 53-58
20. Irani AA, Schlechter NM, Craig SS, DeBlois O, Schwartz LB (1986) Two types of human mast cells that have distinct neutral protease compositions. Prov Natl Acad Sci (USA) 83: 4464-4468
21. Isozaki K, Tsujimura T, Nomura S, Morii E, Koshimizu U, Nishimune Y, et al. (1994) Cell type-specific deficiency of c-kit gene expression in mutant mice of milmi genotype. Am J Pathol 145: 827-836
22. Jippo T, Morii E, Tsujino K, Tsujimura T, Lee YM, Kim DK, et al. (1997) Involvement of transcription factor encoded by the mouse mi locus (MITF) in expression of p75 receptor of nerve growth factor in cultured mast cells of mice. Blood 90: 2601-2608
23. Kitamura Y, Go S, Hatanaka K (1978) Decrease of mast cells in W/W mice and their increase by bone marrow transplantation. Blood 52: 447-452
24. d anemic mice. Blood 53: 492-497
25. Kitamura Y, Yokoyama M, Matsuda H, Ohno T, Mori KJ (1981) Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature 291: 159-160
26. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, et al. (1996) Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88: 995-1004
27. Kröber SM, Horny H-P, Ruck P, Kämmerer U, Geiselhart A, Handgretinger R, et al. (1997) Mastocytosis: reactive or neoplastic? J Clin Pathol 5: 525-527
28. Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR (1991) Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med 91: 612-624
29. Lennert K, Parwaresch MR (1979) Mast cells and mast cell neoplasia: a review. Histopathology 3: 349-365
30. Li WV, Kapadia SB, Sonmez-Alpan E, Swerdlow SH (1996) Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol 9: 982-988
31. Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, et al. (1993) Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328: 1302-1307
32. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, et al. (1996) Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establish- ment of clonality in a human mast cell neoplasm. Nat Genet 12: 312-314
33. Metcalfe DD (1991) Classification and diagnosis of mustocytosis: current status. J Invest Dermatol 96: 2S-4S
34. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. (1995) Identification of a point mutation in the catalytic domain of the protooncogene ckit in peripheral blood mononuclcar cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci (USA) 92: 10560-10564
35. Nakata Y, Kimura A, Katoh O, Kawaishi K, Hyodo H, Abe K, et al. (1995) c-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 91: 661-663
36. Parwaresch MR, Horny H-P, Lennert K (1985) Tissue mast cells in health and disease. Pathol Res Pract 179: 439-461
37. Pignon JM, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, et al. (1997) A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 96: 374-376
38. Prokocimer M, Polliack A (1981) Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 75: 34-38
39. Razin E, Pecht I, Rivera J (1995) Signal transduction in the activation of mast cells and basophils. Immunol Today 16: 370-373
40. - cell population. Blood 84: 2489-2496
41. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T (1987) Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 316: 1622-1626
42. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, et al. (1994) Development of a new, sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 14: 190-204
43. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, et al. (1995) The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96: 2702-2710
44. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748
45. Tachibana M, Perez-Jurado LA, Nakayama A, Hodgkinson CA, Li X, Schneider M, et al. (1994) Cloning of MITF, the human homolog of the mouse microphthalmia gene and assignment to chromosome 3p 14.1-p 12.3. Hum Mol Genet 3: 553-557
46. Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG (1988) Significance of systemic mast cell disease with associated hematologic disorders. Cancer 62: 965-972
47. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, et al. (1994) Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83: 2619-2626
48. Tsujimura T, Morii E, Nozaki M, Hashimoto K, Moriyama Y, Takebayashi K, et al. (1996) Involvement of transcription factor encoded by the mi locus in the expression of ckit receptor tyrosine kinase in cultured mast cells of mice. Blood 88: 1225-1233
49. Valent P (1996) Biology, classification and treatment of human mastocytosis. Wien Klin Wochenschr 108: 385-397
50. Valent P (1994) The riddle of the mast cell: kit (CD117)-ligand as the missing link? Immunol Today 15: 111-114
51. Valent P, Bettelheim P (1992) Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol 52: 333-423
52. Valent P, Bevec D, Maurer D, Besemer J, Di-Padova F, Butterfield JH, et al. (1991) Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci (USA) 88: 3339-3342
53. Valent P, Spanblöchl E, Bankl HC, Sperr WR, Marosi C, Pirc-Danoewinata H, et al. (1994) Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemia blast crisis. Blood 84: 4322-4332
54. Werle E, Schneider C, Renner M, Volker M, Fiehn W (1994) Convenient single-step, one tube purification of PCR products for direct sequencing. Nucleic Acids Res 22: 4354-4355
55. Wong KF, Chan JK, Chan JC, Kwong YL, Ma SK, Chow TC (1991) Concurrent acute myeloid leukemia and systemic mastocytosis. Am J Hematol 38: 243-244
56. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. (1990) Stem cell factor (SCF) is encoded at the 57 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224